对Omega-3脂肪酸作为SRP与常规SRP补充剂的有效性进行比较评估:一项随机临床试验
Shrishti Salian1, Prasad V Dhadse2, Ruchita Patil2
1Department of Periodontics and Implantology, Sharad Pawar Dental College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India, Phone: +91 9004318198,
The journal of contemporary dental practice
|October 4, 2024
概括
欧米茄-3脂肪酸,当与缩和根平整 (SRP) 一起使用时,会改善牙周健康结果. 这种辅助疗法在治疗轻度牙周炎方面比单独的SRP更有好处.
科学领域:
- 牙周病学 牙周病学
- 营养科学 营养科学
背景情况:
- 牙周炎是一种普遍的炎症状况,影响牙和支骨.
- 缩放和根平整 (SRP) 是牙周炎的标准机械治疗方法.
- 欧米茄-3脂肪酸具有抗炎性质,可能有利于牙周健康.
研究的目的:
- 为了比较欧米茄-3脂肪酸作为SRP的辅助剂与单独SRP在牙周治疗中的有效性.
- 为了评估欧米茄-3脂肪酸对临床牙周指标的影响.
主要方法:
- 一项为期3个月的随机对照试验,涉及30名患有牙周炎 (II期B级) 的患者.
- 患者被分为两组:一组接受含有omega-3脂肪酸的SRP,另一组仅接受SRP.
- 临床参数包括口袋探测深度 (PPD),牙指数 (GI),出血指数 (BI) 和斑块指数 (PI) 在基线和3个月后被评估.
主要成果:
- 与基线相比,这两组的斑块和出血指数均呈现出统计学上显著的改善.
- 与单独使用SRP相比,添加omega-3脂肪酸的使用导致全口腔斑块指数 (FMPI) 在统计学上显著降低.
- 在3个月后,两组之间没有观察到牙指数 (FMGI) 或口袋探测深度 (PPD) 的显著差异.
结论:
- 与SRP一起的辅助omega-3脂肪酸治疗表明,对牙周参数,特别是斑块和出血指数的益处有所增强.
- 欧米茄-3脂肪酸可以作为一种有益的宿主调制疗法,用于管理轻度至慢性牙周炎.
- 这项研究表明,欧米茄-3脂肪酸可以改善牙周治疗中软和硬组织的结果.
更多相关视频
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...